Epalinges, Switzerland

Apoxis S.a.

Calculating rank
USPTO Granted Patents = 7

% Expired Patents = 57.1


Forward Citations = 157

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Jurg Tschopp (4 out of 10 patents)

silverMedal Pascal Schneider (3 out of 18 patents)

bronzeMedal Catherine A Hession (3 out of 19 patents)

4.  Christine Ambrose (2 out of 17 patents)

5.  Jeffrey Thompson (2 out of 16 patents)

6.  Paul David Rennert (1 out of 33 patents)

7.  Fabienne MacKay (1 out of 8 patents)

8.  Teresa G Cachero (1 out of 7 patents)

9.  Olivier Gaide (1 out of 3 patents)

10.  Jeffrey L Browning (1 out of 43 patents)

11.  Jürg Tschopp (1 out of 2 patents)

12.  Browning Jeffrey (1 out of 1 patent)

13.  Ambrose Christine (1 out of 1 patent)

14.  MacKay Fabienne (1 out of 1 patent)

15.  Tschopp Jurg (1 out of 1 patent)


7 patents:

Company Overview
Apoxis S.a. is a pharmaceutical company specializing in the development of innovative cancer therapies. With a focus on precision medicine, Apoxis aims to provide personalized treatment options for patients with various types of cancers. Through cutting-edge research and development, Apoxis is committed to improving outcomes and quality of life for cancer patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

7 Patents

#4 in Epalinges

#1,341 in Switzerland

Epalinges, CH
Epalinges, Switzerland
Forward Citations = 157

17 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apoxis S.a.. Retrieved from https://idiyas.com/company/apoxis-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…